English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Reversible gene inactivation in the mouse

MPS-Authors

Mallo,  Moisés
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons191144

Kanzler,  Benoit
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons191255

Ohnemus,  Sabine
Department of Developmental Biology, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Mallo, M., Kanzler, B., & Ohnemus, S. (2003). Reversible gene inactivation in the mouse. Genomics, 81(4), 356-360.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002B-9583-6
Abstract
Gene-inactivation techniques in the mouse have become an essential tool for modern biomedical research. Both ubiquitous and tissue-specific inactivation are possible with current approaches, and recent developments facilitate a temporal control of the inactivation process. However, one of the limitations of current procedures is that inactivation is irreversible. We have produced complete and reversible inactivation of the Hoxa2 gene in the mouse using the control elements of the tetracycline-resistance operon. We show that a Hoxa2 allele containing tetracycline operator (tetO) sequences is susceptible to controlled regulation by tTS, a chimeric molecule containing the tetracycline repressor and a transcriptional repressing domain. This inhibition was specific to the tetO-modified allele, did not affect neighboring genes, and was reversible by administration of doxycycline to the pregnant female. This procedure allows the production of gene inactivation that is complete, is reversible, and can be controlled at the spatial and temporal levels.